TY - JOUR
T1 - Gynecologic cancer intergroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix
AU - Hasegawa, Kosei
AU - Nagao, Shoji
AU - Yasuda, Masanori
AU - Millan, David
AU - Viswanathan, Akila N.
AU - Glasspool, Rosalind M.
AU - Devouassoux-Shisheboran, Mojgan
AU - Covens, Alan
AU - Lorusso, Domenica
AU - Kurzeder, Christian
AU - Kim, Jae Weon
AU - Gladieff, Laurence
AU - Bryce, Jane
AU - Friedlander, Michael
AU - Fujiwara, Keiichi
N1 - Publisher Copyright:
© 2014 by IGCS and ESGO.
PY - 2014/11
Y1 - 2014/11
N2 - Clear cell carcinomas of the uterine corpus and cervix are rare gynecological cancers with limited information regarding the pathogenesis and biology. At present, the approach to management is the same as for patients with the more common histological subtypes of endometrioid endometrial cancer and adenocarcinoma of the cervix. Surgical resection is the standard treatment for patients with early-stage disease, but there is no evidence-based approach to direct the management of patients with more advanced-stage disease at presentation or with recurrent disease. We review the epidemiology, pathology, and what is known about both uterine corpus and cervical clear cell cancers and make management recommendations.
AB - Clear cell carcinomas of the uterine corpus and cervix are rare gynecological cancers with limited information regarding the pathogenesis and biology. At present, the approach to management is the same as for patients with the more common histological subtypes of endometrioid endometrial cancer and adenocarcinoma of the cervix. Surgical resection is the standard treatment for patients with early-stage disease, but there is no evidence-based approach to direct the management of patients with more advanced-stage disease at presentation or with recurrent disease. We review the epidemiology, pathology, and what is known about both uterine corpus and cervical clear cell cancers and make management recommendations.
KW - Clear cell carcinoma
KW - Histological feature
KW - Immunohistochemical
KW - Treatment
KW - Uterine cervix
KW - Uterine corpus
UR - http://www.scopus.com/inward/record.url?scp=84936108299&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936108299&partnerID=8YFLogxK
U2 - 10.1097/IGC.0000000000000297
DO - 10.1097/IGC.0000000000000297
M3 - Review article
C2 - 25341588
AN - SCOPUS:84936108299
SN - 1048-891X
VL - 24
SP - S90-S95
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 9
ER -